Efficacy and safety of nivolumab (Nivo) + ipilimumab (Ipi) in patients (pts) with recurrent/metastatic (R/M) cervical cancer: Results from CheckMate 358

Annals of Oncology
October 1, 2019
Cited by 89Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis